Tech Company Financing Transactions
Asthmatx Funding Round
Asthmatx, based in Sunnyvale, raised $27 million in investment from HBM Healthcare Investments, Vanguard Ventures and Medventure Associates.
Transaction Overview
Company Name
Announced On
12/19/2005
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series C
Investors
HBM Healthcare Investments (Lead Investor)
Vanguard Ventures (Lead Investor)
Proceeds Purpose
This financing will be used to complete the company's FDA approved study and start market development activities. Key asthma centers in the U.S., and five other countries, are participating in the AIR2 Trial.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
888 Ross Dr.
Sunnyvale, CA 94089
USA
Sunnyvale, CA 94089
USA
Phone
Website
Email Address
Overview
Asthmatx, Inc. is focused on helping patients with asthma breathe easier. We are developing an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glen French
Browse more venture capital transactions:
Prev: 12/19/2005: Hypnion venture capital transaction
Next: 12/19/2005: meebo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs